Company: GEHC
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001932393-25-000007
Chunk: 0

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-03-31
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive Agreement.

On March 27, 2025, GE HealthCare Technologies Inc. (the “ Company”) entered into (i) a 364-Day Revolving Credit Agreement (the “2025 364-Day Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N. A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion, and (ii) a Credit Agreement (the “2025 Credit Agreement”) among the Company, JPMorgan Chase Bank, N. A., as administrative agent, and the lenders named therein, which provides for a senior unsecured revolving credit facility in an aggregate committed amount of $3.0 billion. The 2025 Credit Agreement and the 2025 364-Day Revolving Credit Agreement are each referred to herein as a “ New Credit Agreement” and collectively as the “ New Credit Agreements.” The 2025 364-Day Revolving Credit Facility replaces the 364-Day Revolving Credit Agreement, dated as of December 11, 2024 (the “2024 364-Day Revolving Credit Agreement”), among the Company, Citibank, N. A., as administrative agent, and the lenders named therein, which provided for a $1.0 billion 364-day senior unsecured revolving credit facility and which was terminated on March 27, 2025. The 2025 Credit Agreement replaces the Credit Agreement, dated as of November 4, 2022 (the “2022 Credit Agreement”), among the Company, Citibank, N. A., as administrative agent, and the lenders named therein, which provided for a $2.5 billion senior unsecured revolving credit facility and which was terminated on March 27, 2025.

The credit facilities provided under the 2025 364-Day Revolving Credit Agreement and the 2025 Credit Agreement will mature on March 26, 2026 and March 27, 2030, respectively.

The interest rate applicable to loans under the New Credit Agreements is (x) with respect to borrowings in U. S. Dollars, at the Company’s option, equal to either an alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-month interest period, (y) with respect to borrowings in Euros, the EURIBOR rate for a one-, three-,